What is Gilson?
Founded in 1957 and headquartered in Middleton, Wisconsin, Gilson operates as a third-generation family-owned enterprise. The company specializes in the development of sophisticated liquid handling, purification, and extraction systems designed to streamline workflows for life scientists. By maintaining a focus on precision and reliability, Gilson has established itself as a critical partner in academic, pharmaceutical, and biotechnology research environments. Its longevity in the market is a testament to its ability to adapt to the evolving needs of the scientific community while maintaining the core values of a family-led organization.
How much funding has Gilson raised?
Gilson has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Gilson
PPP
Public-Private Partnership
What's next for Gilson?
With this major strategic investment, Gilson is well-positioned to accelerate its research and development initiatives, particularly in the automation of complex laboratory processes. The capital will likely be deployed to enhance the company's digital infrastructure and expand its global distribution network. As the life sciences industry shifts toward high-throughput screening and automated diagnostics, Gilson's focus on precision instrumentation will be vital. The firm is expected to leverage this financial momentum to maintain its competitive edge, potentially exploring new frontiers in sample preparation and analytical chemistry to support the next generation of scientific discovery.
See full Gilson company page
